What medications should men with benign prostatic hyperplasia (BPH) take?
Clinical validation shows that benign prostatic hyperplasia (BPH) in men is relatively difficult to treat, with a prolonged treatment course. Moreover, inappropriate treatment or inadequate care may lead to recurrent episodes, making the condition relatively stubborn and refractory. However, BPH is not equivalent to an incurable disease. With appropriate therapeutic strategies and attention to key treatment principles, patients can achieve significant clinical improvement and restore good health. Below, we introduce commonly used medications for BPH—offering you renewed confidence and hope.

What Medications Should Men with Benign Prostatic Hyperplasia Take?
Antibiotic Therapy
Antibiotics represent one of the most common treatment approaches for BPH. However, due to the unique anatomical structure of the prostate gland—which features a dense fibromuscular stroma and a blood–prostate barrier—systemic drug penetration into prostatic tissue is often limited. Consequently, antibiotic efficacy tends to be suboptimal. Patients should therefore combine pharmacotherapy with comprehensive supportive measures.
Physical Therapy
Physical therapy serves as a primary adjunctive modality in managing BPH. It generally involves the application of physical agents—including sound (e.g., ultrasound), light, electricity, heat, and water—to modulate the body’s internal regulatory mechanisms and thereby restore normal prostate physiology. Importantly, these modalities lack direct antimicrobial activity and thus function solely as supportive treatments.
Traditional Chinese Medicine (TCM)
Traditional Chinese medicine offers effective adjunctive therapy for BPH. Rooted in TCM’s holistic diagnostic and therapeutic philosophy—particularly syndrome differentiation (zheng-hou)—this approach emphasizes systemic regulation rather than isolated symptom suppression. Herbal formulas for BPH typically aim to tonify Qi, strengthen Yang, and nourish the Kidneys, thereby enhancing overall immunity and restoring urogenital balance. Given BPH’s chronic and recurrent nature, integrative supportive care—including TCM—is critically important; patients must therefore accord it due priority.
Surgical Intervention
Surgical options include palliative procedures such as bilateral orchidectomy and transurethral resection of the prostate (TURP), as well as open surgeries—including suprapubic transvesical prostatectomy, retropubic prostatectomy, and perineal prostatectomy. However, surgery carries substantial risks and high associated costs. Careful consideration must be given to institutional capabilities, surgeon expertise, and procedural experience when selecting an operative approach. Furthermore, surgical resection rarely removes the entire prostate gland; residual prostatic tissue remains susceptible to future pathology. Surgery should therefore be reserved for cases where conservative management has failed—and only after thorough risk–benefit assessment.
We hope the above information proves helpful. Wishing you good health and happiness!